O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+6.96%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$7.91B
AUM Growth
+$7.91B
(+12%)
Cap. Flow
+$959M
Cap. Flow
% of AUM
12.12%
Top 10 Holdings %
Top 10 Hldgs %
33.78%
Holding
159
New
26
Increased
22
Reduced
25
Closed
17
Top Buys
| 1 |
Prelude Therapeutics
PRLD
|
$470M |
| 2 |
PMV Pharmaceuticals
PMVP
|
$260M |
| 3 |
AFIB
Acutus Medical, Inc. Common Stock
AFIB
|
$163M |
| 4 |
CalciMedica
CALC
|
$56.9M |
| 5 |
Theravance Biopharma
TBPH
|
$54.2M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$128M |
| 2 |
Cigna
CI
|
$82.5M |
| 3 |
Natera
NTRA
|
$81.6M |
| 4 |
Glaukos
GKOS
|
$46.5M |
| 5 |
Alector
ALEC
|
$34.2M |
Sector Composition
| 1 | Healthcare | 98.49% |
| 2 | Financials | 0.64% |
| 3 | Technology | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Passage Bio
PASG
$22.7M
| $91.3M | 1.15% | 6,962,899 | – | – |
|
|
TCDA
27
DELISTED
Tricida, Inc. Common Stock
TCDA
| $87.1M | 1.09% | 9,614,280 | – | – |
|
28
Intuitive Surgical
ISRG
$170B
| $80M | 1.01% | 112,800 | – | – |
|
29
Adicet Bio
ACET
$59.9M
| $79.8M | 1% | 6,708,507 +1,878,120 | +39% | +$22.3M |
|
30
Centene
CNC
$14.3B
| $77.9M | 0.98% | 1,335,700 | – | – |
|
31
Agios Pharmaceuticals
AGIO
$2.19B
| $77.3M | 0.97% | 2,207,321 +478,900 | +28% | +$16.8M |
|
32
Sarepta Therapeutics
SRPT
$1.78B
| $75.7M | 0.95% | 539,049 -20,600 | -4% | -$2.89M |
|
33
Oric Pharmaceuticals
ORIC
$994M
| $73.1M | 0.92% | 2,921,967 | – | – |
|
34
Aurinia Pharmaceuticals
AUPH
$1.58B
| $70M | 0.88% | 4,754,000 +3,557,653 | +297% | +$52.4M |
|
|
XLRN
35
DELISTED
Acceleron Pharma Inc.
XLRN
| $67.6M | 0.85% | 601,066 +473,566 | +371% | +$53.3M |
|
36
Keros Therapeutics
KROS
$618M
| $64.8M | 0.81% | 1,679,417 | – | – |
|
37
Exelixis
EXEL
$10.1B
| $58.8M | 0.74% | 2,404,100 | – | – |
|
|
LOGC
38
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
| $58.7M | 0.74% | 6,466,783 | – | – |
|
|
DCPH
39
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $57.7M | 0.73% | 1,125,700 | – | – |
|
|
40
CalciMedica
CALC
$37.7M
| $56.9M | 0.72% | +4,475,847 | New | +$56.9M |
|
41
Edwards Lifesciences
EW
$47.8B
| $56.4M | 0.71% | 706,500 +176,100 | +33% | +$14.1M |
|
42
Enliven Therapeutics
ELVN
$1.2B
| $55.3M | 0.7% | 2,719,902 | – | – |
|
43
Eledon Pharmaceuticals
ELDN
$155M
| $54.4M | 0.68% | 3,183,314 | – | – |
|
|
NSTG
44
DELISTED
NanoString Technologies, Inc.
NSTG
| $52.9M | 0.66% | 1,183,100 -9,300 | -0.8% | -$416K |
|
45
CRISPR Therapeutics
CRSP
$4.71B
| $52.7M | 0.66% | 630,004 -67,520 | -10% | -$5.65M |
|
46
eHealth
EHTH
$118M
| $50.4M | 0.63% | 638,558 | – | – |
|
47
TELA Bio
TELA
$70.5M
| $50.1M | 0.63% | 3,027,542 | – | – |
|
48
Progyny
PGNY
$2.04B
| $49.3M | 0.62% | 1,675,500 +1,334,496 | +391% | +$39.3M |
|
49
MeiraGTx Holdings
MGTX
$587M
| $49.2M | 0.62% | 3,713,820 | – | – |
|
50
AtriCure
ATRC
$1.84B
| $49M | 0.62% | 1,228,189 | – | – |
|